After-Hours Stock Movers 02/04: (USNA) (MKSI) (PYPL) Higher; (PLT) (KN) (ZIOP) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Stifel Reiterates Buy Rating on Nike (NKE) Following Showcase
February 6, 2020 8:02 AM ESTStifel analyst Jim Duffy reiterated a Buy rating and $110.00 price target on Nike (NYSE: NKE) following an event in New York. NIKE showcased product innovations to be launched around the Tokyo Olympics this summer.
The show featured a diverse range of Olympic/Paralympic... More
Ziopharm Oncology (ZIOP) Prices 27.83M Share Common Offering at $3.25/Sh
February 5, 2020 9:03 AM ESTZiopharm Oncology, Inc. (NASDAQ: ZIOP) today announced the pricing of an underwritten public offering of 27,826,086 shares of its common stock at a public offering price of $3.25 per share. Ziopharm has granted the underwriters a 30-day option to purchase up to an additional 4,173,912... More
Knowles Corp (KN) PT Lowered to $21 at Susquehanna
February 5, 2020 7:55 AM ESTSusquehanna analyst Christopher Rolland lowered the price target on Knowles Corp (NYSE: KN) to $21.00 (from $25.00) while maintaining a Positive rating.
The analyst commented, "While we thought the company had matured beyond a pattern of common resets, we were wrong, as management cut expectations once again and added execution risk for 2020."
... MoreSunTrust Reiterates Buy Rating on New Relic (NEWR) Following 3Q Report
February 5, 2020 7:23 AM ESTSunTrust analyst Joel Fishbein Jr. reiterated a Buy rating and $85.00 price target on New Relic (NYSE: NEWR) following the company's 3Q earnings report. The Company reported $153M of revenue for 3Q20, ahead of consensus at $149M and the high end of guidance at... More
BMO Capital Downgrades New Relic (NEWR) to Market Perform
February 5, 2020 4:40 AM ESTBMO Capital analyst Keith Bachman downgraded New Relic (NYSE: NEWR) from Outperform to Market Perform with a price target of $72.00 (from $78.00).
The analyst comments "While we acknowledge that NEWR has an inexpensive valuation at less than 5x revs, we are skeptical about... More
